111 algorithm-development-"Prof"-"Prof"-"Prof" Postdoctoral positions at University of Oxford
Sort by
Refine Your Search
-
NHS Foundation Trust. The post holder will be a member of the Retinal Disease and Repair Group (Xue Lab) with responsibility for carrying out research to develop advanced therapies for inherited
-
scientists, forming small teams focused on ambitious, ‘blue sky’ research for novel methods development relevant for drug discovery analysis pipelines, trial design and operational efficiency. Led by Professor
-
of contexts. About you The successful applicant will be able to present information on research progress and outcomes, communicate complex information, orally, in writing and electronically and prepare
-
-year, renewable, high-profile research initiative funded by the European Commission, bringing together leading research teams from across the Eurozone to develop state-of-the-art multimodal LLMs. This is
-
researchers will extend and apply the ideas of active matter physics in biological contexts, developing theories and cell-scale and continuum computational models. The work will focus on identifying physical
-
We are seeking to appoint a Senior Postdoctoral Researcher in Statistical Machine Learning and Deep Generative Modelling to apply and develop cutting-edge deep generative probabilistic models
-
. The role spans two cutting-edge research projects developing digital tools for faster, smarter battery testing and advanced management systems to enhance battery performance in heavy industry. You’ll develop
-
advanced imaging and behavioural techniques in mice; and adapt existing and develop new scientific techniques and experimental protocols, with a particular focus on in vivo animal models (mice
-
lab has developed the OrthoFinder comparative genomic methods. OrthoFinder has become widely-used in comparative genomics research, it powers many popular databases of online genomic information, and
-
world-leading researchers from Oxford, Harvard, and other premier institutions to develop innovative gene-silencing and gene-editing technologies targeting the underlying causes of genetic heart diseases